Antibody response after one and two doses of the BNT162b2
vaccine in nursing home residents: The CONsort-19 study
Hubert Blain, MD, PhD,1 Edouard Tuaillon MD,
PhD,2 Lucie Gamon,3 Amandine Pisoni
PhD,2 Stéphanie Miot MD, PhD,1 Yves
Rolland MD, PhD,4 Marie-Christine Picot MD,
PhD,3 Jean Bousquet MD, PhD5,6
- Department of Internal Medicine and Geriatrics, MUSE University,
Montpellier, France.
- INSERM U 1058/EFS, University hospital, Montpellier, France
- Clinical research and epidemiology unit, University hospital,
Montpellier, France
- Gérontopôle de Toulouse, INSERM 1027; Toulouse, France
- Clinical research and epidemiology unit, University hospital,
Montpellier, France
- Department of Dermatology and Allergy, Universitätsmedizin, Berlin,
Germany
- University hospital, Montpellier, France
Running title: Antibody level after BNT162b2 vaccine